About Immunostics
Immunostics is a Healthcare company based in Ocean Township (United States) founded in 1983, and was acquired by Boditech Med in March 2016. Rapid diagnostic tests, kits, and reagents for diseases are developed. Immunostics has raised $3 million across 2 funding rounds from investors including Boditech Med. The company has 15 employees. Immunostics offers products and services including hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag. Its focus areas include Diversified Diagnostics. Its legal entity is IMMUNOSTICS, INC.
Company details
Immunostics develops microbiological, serological and immunological diagnostic kits and reagents. The company offers products covering a wide range of disease areas such as oncology, womens health, infectious disease, respiratory and toxicology. It also develops and market a wide range of lateral flow tests including Fecal Occult Blood, Strep, Pregnancy, Mono, H. Pylori,etc. The company was sold in March 2016 and operates as a subsidiary of Boditech Med.
- Headquarters Ocean Township, United States
- Employees 15
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website immunostics.com
- Social LinkedIn Facebook
- Acquired by Boditech Med (Mar 2016)
- Legal Name Immunostics, Inc.
- Total Equity Funding$3M (USD)
in 2 rounds
- Latest Funding Round$3M (USD), Series A
Dec 2016
- Investors
- Employee Count15
- Acquired byBoditech Med
(Mar 2016)
Products & Services of Immunostics
Immunostics offers a comprehensive portfolio of products and services, including hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag.
Device for testing heart disease and hormonal disorders.
Test for detecting blood in stool related to cancer.
Rapid antigen test for COVID-19 detection at home.
Funding Insights of Immunostics
Immunostics has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 2
- Last Round Series A — $3M
- First Round $700,017
(Sep 2016)
All 2 funding rounds of Immunostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $3M | Series A | – | – | – |
| Sep 2016 | $700,017 | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Immunostics
Immunostics has secured backing from 1 investor. Prominent investors backing the company include Boditech Med.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developing in vitro diagnostics analyzer instruments and reagents | 1998 | boditech.co.kr |
Investor details for Immunostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Immunostics
4 dated milestones of Immunostics across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Immunostics is founded.
- Exit Acquired by Boditech Med.
- Funding First funding round of $700K.
- Funding Latest funding round, Series A, of $3.0M.
Top companies in Diagnostics & Lab Tech
3 companies that operate in the same segment as Immunostics (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | 336 | ||
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | |||
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | USD 4.45 M | 54 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Immunostics
Complete news archive for Immunostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunostics
Immunostics was founded in 1983 and raised its 1st funding round 33 years after it was founded.
Immunostics is headquartered in Ocean Township, United States. It is registered at Ocean Township, New Jersey, United States.
Immunostics is a funded company, having raised a total of $3M across 2 funding rounds to date. The company's 1st funding round was a Unspecified of $700.02K, raised on Sep 2016.
Immunostics has 15 employees.
Immunostics develops microbiological, serological and immunological diagnostic kits and reagents. The company offers products covering a wide range of disease areas such as oncology, womens health, infectious disease, respiratory and toxicology. It also develops and market a wide range of lateral flow tests including Fecal Occult Blood, Strep, Pregnancy, Mono, H. Pylori,etc. The company was sold in March 2016 and operates as a subsidiary of Boditech Med.
Immunostics offers hemochroma PLUS, hema-screen SPECIFIC GOLD, and Swab-N-Go Home Test COVID-19 Ag.
Immunostics has 1 investor. Key investors include Boditech Med.
Immunostics operates through Immunostics, Inc..
Yes. Immunostics was acquired by Boditech Med in March 2016.